Compare
February 22, 2025 2025-02-22 23:41Compare
| Nabota 50U remove | Neuronox 200U remove | Regenovue Fine Plus remove | Neotox 100U remove | Meditoxin 150U remove | Monalisa Hard Lidocaine remove | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Nabota 50U remove | Neuronox 200U remove | Regenovue Fine Plus remove | Neotox 100U remove | Meditoxin 150U remove | Monalisa Hard Lidocaine remove | ||||||||||||
| Image |  |  |  |  |  |  | ||||||||||||
| SKU | FM-02-15591 | FM-13-93819 | FM-02-15542 | FM-13-32511 | FM-02-15588 | FM-02-15537 | ||||||||||||
| Rating | ||||||||||||||||||
| Price | $41.00 | $109.00 | $42.00 | $62.00 | $79.00 | $34.00 | ||||||||||||
| Stock | 1000 in stock | 1000 in stock | 1000 in stock | 1000 in stock | 1000 in stock | 1000 in stock | ||||||||||||
| Availability | 1000 in stock | 1000 in stock | 1000 in stock | 1000 in stock | 1000 in stock | 1000 in stock | ||||||||||||
| Add to cart | ||||||||||||||||||
| Description | ||||||||||||||||||
| Content | Purpose of Nabota 50U:
The product has contraindications. We are not responsible for any negative effects that you may encounter after administering products by yourself. It is recommended to consult a doctor or medical professional for any procedure. | Description It appears as a lyophilized white powder for injection in a colorless transparent vial. Indication and Usage 1. NEURONOX® is indicated for the treatment of benign essential blepharospasm in patients 18 years of age and older. 2. NEURONOX® is indicated for the treatment of equinus foot deformity due to spasticity in pediatric cerebral palsy patients 2 years of age and older. 3. Temporary improvement of serious glabellar wrinkles ranging from moderate to severe associated with corrugators muscle and/or procerus muscle activities in adults over the age of 20 and below the age of 65. 4. Muscle spasticity : NEURONOX® is indicated for the treatment of upper limb spasticity associated with stroke in patient 20 years of age and older. Dosage and Administration 1. Blepharospasm For blepharospasm, reconstituted NEURONOX® (see Dilution Table) is injected using a sterile, 27 - 30 gauge needle without electromyographic guidance. The initial recommended dose is 1.25 - 2.5 U (0.05 mL to 0.1 mL volume at each site) injected into the medial and lateral pre-tarsal orbicularis oculi of the upper lid and into the lateral pre-tarsal orbicularis oculi of the lower lid. In general, the initial effect of the injections is seen within three days and reaches a peak at one to two weeks post-treatment. Each treatment lasts appro xi mately th ree month s, fol low ing whic h the procedu re can be repeated. At repe at treatment sessions, the dose may be increased up to two-fold if the response from the initial treatment is considered insufficient-usually defined as an effect that does not last longer than two months. However there appears to be little benefit obtainable from injecting more than 5.0 U per site. Some tolerance may be found when the drug is used in treating blepharospasm if treatments are given any more frequently than every three months, and is rare to have the effect be permanent. The cumulative dose of NEURONOX® treatment in a 30-day period should not exceed 200 U. | Scope of Regenovue Fine Plus:
The product has contraindications. We are not responsible for any negative effects that you may encounter after administering products by yourself. Consulting a doctor or medical professional is recommended prior to any procedure. | Botulinum toxin type A Designed to remove wrinkles and contour slim lines. The effect lasts a long time for 6-12 months. High purity product with low resistance to rust, complies with cGMP (FDA, EMA) standards for safety, rapid improvement of skin and wrinkles and treatment of larger muscles. 55% less protein, significantly reduces resistance to continuous treatments. High pH 6/7, ideal pH level for minimal pain after injection. 99.8% Absolute purity, ensures high biological activity for a quick start. | disadvantages of meditoxin 150U:
| Scope of Monalisa Hard Lidocaine:
The effect of the procedure lasts from 6 to 12 months. Product composition: Hyaluronic acid 20 mg/ml, Lidocaine 0.3% Monalisa Hard Lidocaine 1 syringe ? 1.0 ml per pack Needle size: 30G Manufacturer: GENOSS Сo., Ltd., South Korea | ||||||||||||
| Weight | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||
| Additional information |
|
|
|
|
|
|
